Topics

Tyme, Inc. Company Profile

01:44 EST 12th December 2019 | BioPortfolio

Tyme is a pharmaceutical company focused on discovering and developing highly targeted cancer therapeutics for a broad range of oncology indications. Tyme is the originator of what it believes to be a novel, proprietary treatment regimen consisting of a rationally-designed combination of therapeutic agents aimed at exploiting the aberrant metabolic characteristics of cancer cells as well as activating the endogenous immune response against tumors. Tyme's approach is hypothesized to permit selective elimination of cancer cells, while simultaneously improving patients' well-being, particularly with respect to pain severity and functional independence.


News Articles [46 Associated News Articles listed on BioPortfolio]

TYME Provides Updated Data on TYME-88-Panc Phase II Study

Tyme Technologies (NASDAQ:TYME) has provided an update on its open-label Phase 2 TYME-88-Panc study. As quoted in the press release: The data from the TYME-88-Panc study were presented at the European...

TYME Launches TYME-88-PANC Trial

The company's TYME-99-Panc trial will evaluate its candidate SM-88 in patients with metastatic pancreatic cancer. The post TYME Launches TYME-88-PANC Trial appeared first on Investing News Network.

Tyme Technologies (TYME) Presents At BioNJ BioPartnering Conference - Slideshow

Tyme Technologies, Inc. (TYME) CEO Steve Hoffman on Q2 2020 Results - Earnings Call Transcript

Tyme Technologies, Inc.'s (TYME) CEO Steve Hoffman on Q4 2019 Results - Earnings Call Transcript

TYME Technologies Announces New Collaboration with NYU Langone to Advance TYME’s Cancer Metabolism-Based Therapy, SM-88

NEW YORK, July 29, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company, announced a new research collaboration with NYU Langone Health to advance th...

TYME Launches Pivotal Stage of TYME-88-PANC Trial to Evaluate SM-88 for Third-Line Treatment of Patients with Metastatic Pancreatic Cancer

Oral SM-88 represents a new approach designed to selectively disrupt protein synthesis in cancers with demonstrated responses in 15 different cancer types across four separate studiesData prese...

TYME Presents Updated Data at ESMO GI 2019 from TYME-88-Panc Phase II Study Demonstrating Encouraging Overall Survival Trends in Patients with Advanced Pancreatic Cancer

In this poor prognosis population, SM-88 demonstrated median overall survival (OS) of 6.4 months as of April 25, 2019 Efficacy indicators showed strong correlation with greater overall survival (OS)...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [5 Associated Companies listed on BioPortfolio]

Tyme, Inc.

Tyme is a pharmaceutical company focused on discovering and developing highly targeted cancer therapeutics for a broad range of oncology indications. Tyme is the originator of wha...

Tyme Technologies, Inc.

Tyme, Inc. is a pharmaceutical company focused on discovering and developing highly targeted cancer therapeutics for a broad range of oncology indications. Tyme, Inc. is the origi...

LineaRx, Inc.

Tyme Technologies, Inc., is an emerging biotechnology company developing cancer therapeutics that are intended to be broadly effective across tumor types and have low toxicity profiles. Unlike target...

Tyme Technologies Inc.

Tyme Technologies, Inc.

More Information about "Tyme, Inc." on BioPortfolio

We have published hundreds of Tyme, Inc. news stories on BioPortfolio along with dozens of Tyme, Inc. Clinical Trials and PubMed Articles about Tyme, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Tyme, Inc. Companies in our database. You can also find out about relevant Tyme, Inc. Drugs and Medications on this site too.

Quick Search

Relevant Topics

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record